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The P19CL6 cell line is a useful model to study cardiac diﬀerentiation in vitro. However, large variations were noticed in the
diﬀerentiation rates among previous reports as well as our individual experiments. To overcome the unstable diﬀerentiation, we
established P19CL6-A1, a new clonal derivative of P19CL6 that could diﬀerentiate into cardiomyocytes more eﬃciently and stably
than the parent using the double stimulation with 5-Aza and DMSO based on the previous report. We also introduced a new
software, Visorhythm, that can analyze the temporal variations in the beating rhythms and can chart correlograms displaying the
oscillated rhythms. Using P19CL6-A1-derived cardiomyocytes and the software, we demonstrated that the correlograms could
clearly display the enhancement of beating rates by cardiotonic reagents. These indicate that a combination of P19CL6-A1 and
Visorhythm is a useful tool that can provide invaluable assistance in inotropic drug discovery, drug screening, and toxicity testing.
1.Introduction
Heart disease, including coronary heart disease, cardiomy-
opathy, and heart failure, causes functional deterioration
and/or failure as well as myocardial cell death. It is one of
the leading causes of death in advanced countries because
adult cardiomyocytes are highly diﬀerentiated and have a
limited regenerative capacity; therefore, signiﬁcant loss of
myocardium is mostly irreversible. Cell regeneration therapy
isapromisingnewapproachformyocardialrepair,[1,2]and
in this context, there has been considerable basic research
on the mechanisms of cell development into cardiomyocytes
using somatic and embryonic stem (ES) cells as well as
embryonic carcinoma cells [3–6]. P19 embryonic carcinoma
cells are one of the ﬁrst among such cells to demonstrate
diﬀerentiation into cardiomyocytes [7] and have contributed
extensively to the elucidation of the development mecha-
nisms from stem cells into cardiomyocytes [4, 5, 8]. P19
cells are derived from a teratocarcinoma in CH3/He mice
and can diﬀerentiate into all 3 germ layers [9]. Culture
and diﬀerentiation of the cells is simple, and this advantage
has enabled their extensive application for decades. They
continuouslygrowinserum-supplementedmedia,canretain
an undiﬀerentiated cell state without a feeder cell layer
unlike ES cells, and their diﬀerentiation can be controlled
by nontoxic reagents. Primarily, cell aggregate formation
in suspension culture under 0.5–1.0% dimethyl sulfoxide
(DMSO)followedbythereagentapplicationinadhesioncul-
ture has been used to induce cardiomyocyte diﬀerentiation
of P19 cells [7, 8, 10]. We examined the diﬀerentiation of
P19 cells into cardiomyocytes by the above general method;
however, it resulted in large variations in the diﬀerentiation
rate and low diﬀerentiation eﬃciencies among individual
experiments, even though high diﬀerentiation eﬃciencies
have been reported previously [7, 8, 10].
P19CL6 cells, clonal derivatives of P19 cells, were estab-
lished by Habara-Ohkubo [11]. These subline cells can be
diﬀerentiated into spontaneously beating cardiomyocytes by
treatment with 1% DMSO in adhesion culture over a period
of 10 days or weeks without cell aggregate formation in
suspension culture and more eﬃciently as compared to the
parent cells. Therefore, P19CL6 cells may be more useful to2 Journal of Biomedicine and Biotechnology
examine the diﬀerentiation mechanisms of cardiomyocytes
in vitro. Recently, Ohtsu et al. [12] introduced a double
stimulation method for cardiomyocyte diﬀerentiation from
P19CL6 cells. They demonstrated that cells exposed to
10μM 5-azacytidine (5-Aza) for 24 hours prior to treatment
with 1% DMSO diﬀerentiated into cardiomyocytes more
eﬀectively than the widely used single stimulation method
described above. In order to produce a large number of
cardiomyocytes, we induced diﬀerentiation of P19CL6 cells
into cardiomyocytes by the double stimulation method to
examine the diﬀerentiation eﬃciency; however, it resulted in
large variations in the diﬀerentiation rates among individual
experiments, as in the case of P19 cells. However, notably,
the double stimulation method elicited diﬀerentiation from
P19CL6 cells most eﬃciently among the several diﬀerenti-
ation methods as long as it was in vitro in our laboratory.
We also noticed large variations in the diﬀerentiation rates
among previous reports on P19CL6 [12–14]a sw e l la sP 1 9
cells [8, 10, 15, 16] and this may imply a fundamental
problem of the cells in themselves and/or the diﬀerentiation
methods. To overcome this diﬃculty, we attempted to estab-
lish a subline from P19CL6 cells, and accordingly, we could
introduceanewsublineofcells,thatis,P19CL6-A1cells,that
could eﬃciently and stably diﬀerentiate into cardiomyocytes
by a diﬀerentiation method based on the double stimulation
method with many modiﬁcations. In the present study,
we also introduce a software program, VisoRhythm, which
can analyze the temporal variations in the beating rhythms
on moving images and chart correlograms displaying the
oscillated rhythms on a Windows computer. Because the
spontaneously beating cardiomyocytes diﬀerentiated from
P19CL6-A1 cells form large cell clusters, their contractions
are large and strong. This feature may prove to be quite
suitable for oscillated rhythm analysis based on moving
images, and accordingly, we used this software to successfully
display the increase in the cardiomyocyte beating rates on
correlograms and dose-response curves on treatment with
serially diluted cardiotonic reagents. This may indicate that
P19CL6-A1 cells and the above software are useful tools for
pharmacological screening tests.
2.MaterialsandMethods
2.1. Animals. Balb/c mice of either sex maintained under
standard housing and feeding conditions were used. The
ventricles of the hearts dissected from mice aged 8 weeks and
16.5dayspostcoitum(dpc)fetuseswereexaminedbyreverse
transcription PCR (RT-PCR). The animal experimentation
protocols were approved by the University’s Animal Research
Committee.
2.2. Cell Culture and Cloning. P19CL6 cells were obtained
from RIKEN BioResource Center (Ibaraki, Japan). The cells
were cultured in a tissue culture-grade dish and grown in
alpha-modiﬁed Eagle’s minimal essential medium (α-MEM;
Sigma-Aldrich Japan K.K., Tokyo) supplemented with L-
glutamine (4 mM; Gibco BRL, Carlsbad, CA) or Dulbecco’s
modiﬁedEagle’sminimalessentialmedium(DMEM;Sigma-
Aldrich Japan K.K.) containing 5–10% heat-inactivated fetal
bovine serum (FBS; JRH Biosciences, Lenexa, KA) and
penicillinandstreptomycin(100U/mLand100μg/mL,resp.;
Sigma-Aldrich Japan K.K.). They were maintained in a 5%
CO2 atmosphere at 37◦C.
Several subclones were isolated from the P19CL6 cells
by the common cloning ring technique. Each clonal colony
was expanded increasingly into larger wells and dishes and
frozen until use. Two types of cell colonies were derived
from a single cell: one, growing horizontally to form a
single cell layer on a dish and the other, growing both
horizontallyandverticallytoformcellaggregatesofmulticell
layers like embryoid bodies or cell aggregates in suspension
culture prepared using bacterial-grade dishes [5, 8, 13].
Both cell types were collected for the cardiac diﬀerentiation
experiment; however, the latter were considerably more
eﬃcient in diﬀerentiating into cardiomyocytes.
Among the several diﬀerentiation methods, the one
proposed by Ohtsu et al. [12]e l i c i t e dm o s te ﬃcient car-
diomyocyte diﬀerentiation from parent P19CL6 cells as
long as the experiment was in vitro in our laboratory;
however, it also led to a fundamental diﬃculty, that is, high
variationsinthediﬀerentiationeﬃcienciesamongindividual
experiments. Hence, we modiﬁed the above method in order
to adapt it to our subclonal cells as well as to the parent cells.
The diﬀerentiation conditions that we primarily considered
were the concentration and/or exposure duration of the
diﬀerentiation reagents, the concentration of FBS in the
culture medium (α-MEM or DMEM), and coating reagents.
They were as follows: 5-azacytidine (5-Aza; Sigma-Aldrich
Japan K.K.): concentration: 5, 10, 15, 20, 30, and 40μMa n d
exposure duration: 24, 48, and 72 hours; dimethyl sulfoxide
(DMSO, Sigma-Aldrich Japan K.K.): concentration: 0.5,
1.0, 1.5, and 2.0%; FBS in the diﬀerentiation medium:
concentration: 2.5, 5.5, 6.5, 7.5, and 10%; and the use of
a culture dish coated with or without collagen (3.0μg/cm2,
Type I-A; Nitta Gelatin Inc., Osaka) or Matrigel (3.0μg/cm2;
BD Biosciences, San Jose, CA). Accordingly, we found
a subclone, designated A1, which is the most eﬃciently
diﬀerentiated into cardiomyocytes under the diﬀerentiation
conditions below and used it for further experiments to
evaluate the diﬀerentiation eﬃciency. We also found the
optimum conditions that could be applied to the parent
P19CL6 cell line, and the use of these conditions yielded
almost the same results as those yielded by the method of
Ohtsu et al. [12]; the description has been provided below.
2.3. Diﬀerentiation. The diﬀerentiation eﬃciencies of the
subline, P19CL6-A1, and the parent cell line, P19CL6, were
compared. The diﬀerentiation conditions were summarized
in Table 1.
The cells were plated at a density of 5.0 × 105 cells/well
on 6-well plates or on a 35-mm tissue culture-grade dish
coated with collagen (3.0μg/cm2) and containing the growth
medium(α-MEMwith6.5%FBSforP19CL6cellsorDMEM
with 7.5% FBS for P19CL6-A1 cells) and were incubated
in a 5% CO2 atmosphere at 37◦C. The next day, when
cells reached ∼95% conﬂuence, the medium was replaced
with a growth medium containing 10μM 5-Aza in order
to induce diﬀerentiation. The P19CL6 and P19CL6-A1 cellsJournal of Biomedicine and Biotechnology 3
Table 1: The conditions of diﬀerentiation protocol and diﬀerentiation eﬃciency for P19CL6 and P19CL6-A1 cells.
Cell line P19CL6 PI9CL6-Al P19CL6
Diﬀerentiation protocol Basal protocol Developed protocol Ohtsu et al. [12]
Medium α-MEM DMEM α-MEM
FBS: concentration 6.5% 7.5% 10%
5-Aza: concentration and incubation time 10μM1 0 μM1 0 μM
24 hours 72 hours 24 hours
DMSO: concentration and incubation time 1% 1% 1%
≥ 16 days ≥ 14 days ∼16 days
Coating Collagen Collagen —
(Type I-A) (Type I-A)
α-actin-positive cell area to total ﬁeld∗ 7.0% 38.3% —
Relative intensity of α-MHC mRNA expression∗∗ 1.0 1.77 —
∗, ∗∗ Diﬀerentiation eﬃciency measured by immunoﬂuorescence microscopy (∗) and RT-PCR (∗∗) on day 16.
were treated with 5-Aza for 24 and 72 hours, respectively,
and the 5-Aza-containing medium was changed every 24
hours.Aftertreatmentwith5-Aza,thecellswereincubatedin
the growth medium containing 1.0% DMSO for more than
16 days. The DMSO-containing medium was also changed
everydayinordertoremovethecelldebrisresultingfromcell
death. The experimental days were numbered consecutively
beginning from the day after the ﬁrst day of treatment with
5-Aza (day 0).
2.4. Immunoﬂuorescence Microscopy. P19CL6 and P19CL6-
A1 cells were cultured on glass coverslips coated with
collagen (3.0μg/cm2). Cells on day 16 were washed twice
with Hanks’ balanced salt solution (HBSS; Sigma-Aldrich
Japan K.K.) and then ﬁxed with 4% paraformaldehyde in
PBS for 30 minutes at 4◦C. After the ﬁxation, cells were
rinsed twice in cold PBS, treated with 0.1% Triton X-100 in
PBS for 20 minutes at room temperature and again rinsed
twice in PBS. In order to reduce autoﬂuorescence, cells were
treated with 50mM NH4Cl in PBS for 10 minutes at room
temperature. Then cells were blocked in a humid chamber
with PBS containing 3% normal goat serum (NGS; Sigma-
Aldrich Japan K.K.) for 30 minutes and then incubated
with the anticardiac α-actin antibody (Sigma-Aldrich Japan
K.K.; 10μg/mL in PBS containing 3% NGS) for 16 hours
at 4◦C. After washing with PBS, cells were incubated with
Alexa488-conjugatedgoatantimouseIgG(Molecularprobes,
Inc., Eugene, OR) for 30 minutes at room temperature,
rinsedinPBSandmountedwithPermaﬂuor(ThermoFisher
Scientiﬁc Inc., Fremont, CA). Cells were photographed with
ﬂuorescence microscopes (IX71, Olympus Co., Tokyo). The
speciﬁcity of the immunoﬂuorescence staining was veriﬁed
by incubations without the primary or secondary antibodies
and no speciﬁc ﬂuorescence was observed in the control.
For quantitative analysis of rates of diﬀerentiation into car-
diomyocytes, we measured ratios of cardiac α-actin-positive
cell areas to total areas of microscopic ﬁelds using Image J
software (ver. 1.41; National Institutes of Health, Bethesda,
MD). For this purpose 10 random ﬁelds per coverslip were
photographed. Autoﬂuorescencefrommultilayercellregions
was rather strong but α-actin-speciﬁc ﬂuorescence was easily
discriminated from the autoﬂuorescence because α-actin-
positive cells emerged as high-intensity cells in cell clusters
(see Figure 2). In this way we counted out autoﬂuorescence
regions. Sixty ﬁelds were examined in each cell type and the
results from six independent experiments were summarized
as mean ± SE. Unpaired t-test was carried out to compare
the diﬀerentiation eﬃciency between the two cell types.
2.5. Reverse Transcription PCR (RT-PCR) Analysis. Total
RNA was isolated from the cultured P19CL6 and P19CL6-
A1 cells on days 0, 3, 7, and 16, and from the cardiac
ventricles of 8-week-old adult mice and 16.5dpc fetuses
using the TRIZOL reagent (Invitrogen Japan K.K., Tokyo).
One microgram of total RNA was transcribed into ﬁrst-
standard cDNA using M-MLV reverse transcriptase, RNase
H
− (Promega, Madison, WI), and oligo (dT) primer accord-
ing to the manufacturer’s instructions. For detection of
GATA4 and Nkx2-5, the speciﬁc transcription factors for
cardiac diﬀerentiation [17], and of the alpha myosin heavy
chain (α-MHC), which is indispensable for cardiomyocyte
contraction, 1μL of the reaction mix (out of the total 25μL)
as the reverse-transcribed DNA template was ampliﬁed by
PCR—40 cycles for GATA4 and Nkx2-5 and 25 cycles
for α-MHC. After ampliﬁcation, the PCR products were
separated on 1.2% agarose gel and visualized by ethidium
bromide staining. The expression levels of GATA4, Nkx2-
5, and α-MHC mRNAs were compared between P19CL6
and P19CL6-A1. They were determined from 3 independent
experiments and normalized by reference to the expres-
sion levels of GAPDH mRNA (23 cycles of PCR). All
analyses were performed on Excel 2007. The values were
expressed as the mean ± SE that was represented by
ratios to the mean values of the P19CL6 cells in the basal
protocol on day 16 as 1.0 according to the diﬀerentiation
protocol. Unpaired t-test was carried out for statistical
analysis. The following primer pairs were used: GATA4,
5 -GTTGTGGTGGTGGGTTTTTC-3  (forward) and 5 -
TTTGATGTTCCTGGGAGAGG-3  (reverse); Nkx2-5, 5 -
TCTCCGATCCATCCCACTTTATTG-3  (forward) and
5 -TTGCGTTACGCACTCACTTTAATG-3  (reverse); α-
MHC, 5 -TACCTCATGGGGCTGAACTC-3  (forward) and4 Journal of Biomedicine and Biotechnology
5 -CGAACATGTGGTGGTTGAAG-3  (reverse); GAPDH,
5 -GACTTCACTCACGGCAAATT-3  (forward) and 5 -
TCCTCAGTGTAGCCCAAGAT-3  (reverse).
2.6. Contraction Rhythm Analysis Based on Moving Images.
The 35-mm dish with the diﬀerentiated cells were placed
in a stage top microscope incubator (ONI-INU-F1; Tokai
Hit, Shizuoka, Japan) mounted on an inverted microscope
(DMIRB, Leica Microsystems Ltd., Heerbrugg, Switzerland)
and incubated at 37◦Ci na5 %C O 2 atmosphere. Phase-
contrast moving images of spontaneously beating cells
were recorded through a CCD camera (COOLPIX4500;
Nikon Co., Tokyo) and digitalized to mpeg2 video ﬁles
(8bits/channel; 704pixels × 480pixels/frame; 30frames/sec)
using an encoder (MTU2400 FX; Canopus Co. Ltd., Kobe,
Japan). The contraction rhythm of the spontaneously
beating cells was analyzed based on the moving images
using the following method based on the data analysis
algorithm on the calculation of correlation coeﬃcient as
reported by Yamauchi et al. [18]. A small area of interest
where brightness clearly oscillated due to the beating was
selected from a moving image, and then, a reference frame
was arbitrarily chosen from the moving image frames.
Temporal variations in the correlation coeﬃcient were
calculated between the values of mean brightness of the
reference frame and those of other frames in the selected
area, and accordingly, a correlogram representing the
contraction rhythm of the beating cells in the area of interest
was displayed by the vertical coeﬃcient and horizontal
time axis. We developed a software program, VisoRhythm,
which calculates the temporal variations in the correlation
coeﬃcient up to 6 rectangle areas (150–400pixels/area)
simultaneously on a single moving image on a Windows
computer. The data can then be directly output into Excel
to chart the correlograms, and the beat-to-beat intervals
are represented by the intervals between the upward and
downward peaks in each correlogram in the selected areas.
We examined the pharmacological reactions of spon-
taneously beating cardiomyocytes diﬀerentiated from the
P19CL6-A1 cells to evaluate whether they are useful cel-
lular tools for pharmacological screening tests. We used
3-isobutyl-1-methylxanthine (IBMX; Sigma-Aldrich Japan
K.K.) and ouabain (Sigma-Aldrich Japan K.K.), which are
well-known potent cardiotonic reagents, for this purpose.
Phase-contrastmovingimagesofspontaneouslybeatingcells
were recorded before and after addition of serial dilutions of
each reagent (10nM, 20nM, 70nM, 200nM, 700nM, 2μM,
7μM, 20μM, and 70μM) into the medium. The beat-to-
beat intervals on exposure to certain concentrations (10nM,
30nM, 100nM, 300nM, 1μM, 3μM, 10μM, 30μM, and
100μM) were obtained from the correlograms calculated on
VisoRhythm. The median eﬀectivedose (ED50) was obtained
from the dose-response curve based on the beating rates on
which the basal and maximum rates were represented by 0
and 100%, respectively.
3. Results
3.1. Diﬀerentiation Conditions and Microscopic Observations.
We selected the diﬀerentiation protocol suggested by Ohtsu
et al. [12] for the P19CL6 cells because this method was
the most eﬃcient for cardiomyocyte diﬀerentiation from
among the several diﬀerentiation methods as long as it was
in vitro in our laboratory. The undiﬀerentiated populations
of the cells, however, considerably proliferated even in the
diﬀerentiation medium containing 1% DMSO as a diﬀer-
entiation inducer and 10% FBS; hence, we reexamined the
optimum concentrationofFBS.We thus obtained aresultant
concentration of approximately 6.5%, and accordingly, the
protocol for the cells was as revised as follows. Subconﬂuent
P19CL6 cells in α-MEM containing 6.5% FBS were treated
with 10μM 5-Aza for 24 hours followed by treatment with
1% DMSO for more than 16 days (basal protocol). In case
of the P19CL6-A1 cells, we modiﬁed the basal protocol by
reexamining the conditions in each step according to the
criteria of (1) rates of appearance of the beating cells per ﬁeld
and (2) dimensions of the beating area under a microscope.
Thecellsshowedarelativelyhighresistanceto5-Aza,andthe
optimum conditions were as follows. Subconﬂuent P19CL6-
A1 cells in DMEM containing 7.5% FBS were treated with
10μM 5-Aza for 72 hours followed by treatment with 1%
DMSO for more than 14 days (developed protocol). We also
examined the diﬀerentiation eﬃciencies in culture dishes
coated with or without collagen or Matrigel and found the
diﬀerentiationtobemoreeﬀectiveoncollagencoateddishes.
The conditions for each protocol and for each cell type are
summarized in Table 1.
We observed the diﬀerentiation processes under an
inverted microscope to compare the morphological diﬀer-
ences between the P19CL6 and P19CL6-A1 cells. Both cell
types grew similarly in the beginning (days 0–5) of the
diﬀerentiation protocols. The P19CL6 and P19CL6-A1 cells
reduced in number during treatment with 5-Aza due to the
damage by the reagent and proliferated slightly everyday
thereafter during treatment with DMSO. The cells started
to grow vertically due to overconﬂuence, and multilayer
cell regions appeared around day 5. On the P19CL6 cells
multilayer cell regions were generally small and appeared
like scattered islands in monolayer cell regions. However,
on P19CL6-A1 cells, they were connected with each other
to form mesh-like structures and expanded to comprise
approximately 70–80% of the total area of the dishes during
the procedure. This feature of the multilayer cell regions
was similar to that of embryoid bodies or aggregates on
culturewithDMSOinthenonadhesivebacteriological-grade
dishes. Beating cells ﬁrst appeared among the P19CL6 cells
diﬀerentiated by the basal protocol on day 10 and among
the P19CL6-A1 cells diﬀerentiated by the developed protocol
on day 11. The clusters of beating cells increased in number
and size thereafter and peaked on day 16 in both cases.
The peaks were retained at least till day 21. The beating
cell clusters from the P19CL6 cells were observed generally
in the monolayer cell regions and less frequently on the
boundary between the monolayer and multilayer regions
(Figure 1(a)). The clusters, composed of small-sized beating
cells densely arranged, were generally small in the monolayer
regions (Figures 1(c) and 1(e)). On the other hand, the
beating cell clusters in the P19CL6-A1 cells appeared mostly
in the multilayer and boundary regions (Figure 1(b)). TheyJournal of Biomedicine and Biotechnology 5
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Figure1:Phase-contrastmicrographsintypicalviewofbeatingcardiomyocytes(CM;enclosedwithawhiteline)diﬀerentiatedfromP19CL6
cells by the basal protocol ((a) and (c)), and P19CL6-A1 cells by the developed protocol ((b) and (d)) on day 16. Cardiomyocytes in (b) form
the large cluster that extends beyond the visual ﬁeld while those in (a) form the small clusters. The clusters of cardiomyocytes in (c) are small
and round in a single cell layer region. They are composed of small-sized beating cells densely arranged. On the other hand, the cluster in
(d) is large and forms a mesh-like sheet structure in multicell layers. It is composed of elongated cardiomyocytes. (e) and (f) are diagrams of
(c) and (d), respectively, in which cardiomyocytes are depicted in Indian red.
were composed of elongated cells and formed mesh-like
sheet structures (Figures 1(d) and 1(f)). They were relatively
large and sometimes extended beyond the visual ﬁeld under
the inverted microscope through a 10× objective lens,
and accordingly, the contractions were large and strong.
Therefore, the beating cells diﬀerentiated from the P19CL6-
A1 cells on day 16 or later were suitable for contraction
rhythm analyses based on moving images.
In order to morphologically identify cardiomyocytes dif-
ferentiated from P19CL6 and P19CL6-A1 cells clearly and to
compare the diﬀerentiation eﬃciencies between the two, we
immunocytochemicallyexaminedthosecellsonday16using6 Journal of Biomedicine and Biotechnology
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Figure 2: Immunoﬂuorescence staining with anticardiac α-actin antibody in P19CL6 cells diﬀerentiated by the basal protocol on day 16 ((a)
and (c)), and P19CL6-A1 cells by the developed protocol on day 16 ((b) and (d)). ((a) and (c)) Cardiac α-actin-positive cells, various in
shape, form relatively small and round clusters. ((b) and (d)) Cardiac α-actin-positive cells, relatively large and elongated in general, formed
mesh-like sheet structures. (e) Quantitative analysis of rates of diﬀerentiation into cardiomyocytes. Ratios of α-actin-positive cell areas to
total areas of microscopic ﬁelds were calculated based on a total of 60 micrographs randomly taken from six independent experiments in
each cell type and summarized as mean ± SE. Unpaired t-test was carried out to compare the diﬀerentiation eﬃciency between the two cells.
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anticardiac α-actin antibody under immunoﬂuorescence
microscopy.Cardiacα-actin-positivecellsfromP19CL6were
various in shape (oval, polygonal, short spindle-shaped) and
generally formed round clusters (Figures 2(a) and 2(c)).
Those from P19CL6-A1 were relatively large and elongated,
and formed mesh-like sheet structures (Figures 2(b) and
2(d)). We measured ratios of cardiac α-actin-positive cell
areastototalareasofmicroscopicﬁelds;thepositivecellareas
were 7.0 ± 1.1% (mean ± SE) of the total areas on P19CL6
while those were 38.3 ± 5.7% on P19CL6-A1. The value on
P19CL6-A1 was 5.5 times and signiﬁcantly higher than that
on P19CL6 (P = .002; Figure 2(e), Table 1).
3.2. Expression of Cardiac Speciﬁc mRNAs. To compare the
diﬀerentiation eﬃcienciesbetweentheP19CL6andP19CL6-
A1 cells, we examined the expression of the cardiac-speciﬁc
transcriptionfactors,GATA4andNkx2-5,andofthecardiac-
speciﬁc myosin heavy chain, α-MHC, by RT-PCR on the
respective cells with the respective diﬀerentiation protocols
listed in Table 1 on days 0, 3, 7, and 16. Both GATA4 and
Nkx2-5werealreadyexpressedinbothP19CL6andP19CL6-
A1 cells on day 0, that is, in the untreated cells (Figure 3(a)).
The expression of the former increased from day 0 to day
16 during treatment in both groups (Figure 3(b)), while
that of the latter dipped on day 3, but increased thereafter
(Figure 3(c)). On day 16, when the appearance rates of the
beating cells per ﬁeld and the dimensions of the beating area
peaked as observed under a microscope, GATA4 expression
did not diﬀer signiﬁcantly between the P19CL6 and the
P19CL6-A1 cells; however, Nkx2-5 expression in the latter
was signiﬁcantly and 1.45 times higher than that in the
former (Figure 3(c)). Alpha-MHC was not expressed till
day 7, although it was clearly expressed on day 16 in both
groups (Figure 3(d)). Its expression in the P19CL6-A1 cells
was signiﬁcantly and 1.77 times higher than that in the
P19CL6 cells (Figure 3(d), Table 1). These results indicated
that P19CL6-A1 cells were more eﬃcient than the parent in
terms of cardiomyocyte diﬀerentiation. We also examined
α-MHC expression in the ventricles of 8-week-old adult
mice and 16.5dpc fetuses by RT-PCR to compare α-MHC
expression in the tissues with that in the P19CL6-A1 cells
diﬀerentiated by the developed protocol on day 16. The
expression levels were higher in the adult tissue than in the
other tissue, but were almost equal between the fetal tissue
and the cells on day 16 (Figure 3(e)).
3.3. Analysis of the Pharmacological Reactions of the Beating
Cells Based on Moving Images. We examined the pharmaco-
logical reactions of the spontaneously beating cells diﬀeren-
tiated from P19CL6-A1 cells by the developed protocol. For
thispurpose,weemployedIBMXandouabainascardiotonic
reagents, and both of them increased the beating rates. The
moving images of the beating cells were recorded before
and after addition of serial dilutions of each reagent. To
determine the temporal variations in the beating rhythms
in detail, we developed the software, Visorhythm, to analyze
them based on moving images and chart correlograms
displaying the oscillated rhythms. Figure 4(a) is an example
of a series of correlograms corresponding to the temporal
variations in the contraction rhythms of the beating cells
treated with 10nM, 300nM, and 10μM; the beating rate
was 1.30 times per second at the basal level and increased
up to 2.30 times per second after the addition of 10μM
IBMX. Figure 4(b) shows the dose-response curve to IBMX
corresponding to the data in Figure 4(a), and its EC50
was 950nM. Figures 4(c) and 4(d) illustrate another series
of correlograms and a dose-response curve to ouabain,
respectively. In this case, its EC50 was 160nM. These data
indicate that the P19CL6-A1 cells and Visorhythm are useful
tools for pharmacological screening tests.
4. Discussions
4.1. Eﬃcient Diﬀerentiation. P19 embryonal carcinoma cells
have been extensively studied for cardiac diﬀerentiation
in vitro and have contributed to the elucidation of the
early events in diﬀerentiation, such as the involvement of
bone morphogenic proteins and their subsequent intra-
cellular signal cascades and oxytocin and its subsequent
activation of the transcription factors GATA4, Nkx2-5, and
so on [5, 7, 8, 10, 19]. For their eﬃcient diﬀerentiation
into cardiomyocytes, prior formation of cell aggregates
in suspension culture under 0.5–1.0% DMSO followed
by reagent application in adhesion culture is required;
however, molecular events occurring during aggregation and
the necessity of their aggregation for diﬀerentiation have
not yet been entirely understood [5]. High cell densities
at least can trigger spontaneous diﬀerentiation from P19
cells without the formation of cell aggregates and reagent
treatment [9, 10]. On the other hand, P19CL6 cells, the
clonal derivative of the P19 cells, eﬃciently diﬀerentiate into
cardiomyocytes on DMSO treatment in adhesion culture
withoutprior formationof cellaggregates,although high cell
densities are required for eﬀective diﬀerentiation [11]. In the
present study, we introduced P19CL6-A1, a clonal derivative
of P19CL6 cells, which diﬀerentiated into cardiomyocytes
most eﬃciently among the 3 cell lines subjected to double
stimulation with 5-Aza and DMSO in adhesion culture as
reported by Ohtsu et al. [12], with many modiﬁcations.
The P19CL6-A1 cells extensively formed multicell layers
in adhesion culture under stimulation with DMSO after
they reached overconﬂuence. They were highly packed in
multicell layers like the cell aggregates of P19 cells in sus-
pension culture. P19CL6-A1-derived cardiomyocytes, which
generally formed large clusters of beating cells, almost always
appeared in the multilayer regions and on the boundary
regions adjacent to the monolayer regions. These ﬁndings,
in addition to the above diﬀerentiation characteristics in
the other 2 cell types, may indicate that cell-to-cell contact
all around, that is, not only from side to side but also
from top to bottom, is a key event in the diﬀerentiation of
P19 cells and their derivatives. Because three-dimensional
contact can be achieved by the formation of multicell
layers, a clonal derivative diﬀerentiating more eﬃciently into
cardiomyocytes than P19CL6-A1 may be established when
the dimensions of the multilayer regions is employed as
a criterion for clonal selection from P19CL6 cells. Further8 Journal of Biomedicine and Biotechnology
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Figure 3: AmpliﬁcationofGATA4,Nkx2-5, andα-MHCmRNAsbyRT-PCR.(a)Expression of GATA4, Nkx2-5, and α-MHCintheP19CL6
cells diﬀerentiated by the basal protocol and the P19CL6-A1 cells by the developed protocol on day 0 and 16, respectively. ((b), (c) and (d))
Densitometric quantiﬁcation of the ampliﬁcation levels of GATA4 (b), Nkx2-5 (c), and α-MHC (d) in the P19CL6 and P19CL6-A1 cells
in the respective diﬀerentiation protocols on day 0, 3, 7, and 16. Data from three independent experiments, normalized to the levels of the
GAPDH ampliﬁcation products, are shown as mean ± SE. Comparisons between the data of P19CL6 and P19CL6-A1 cells were performed
using unpaired t-test. ∗P<. 05 (e) Ampliﬁcation of α-MHC mRNAs by RT-PCR in the P19CL6-A1 cells diﬀerentiated by the developed
protocol with DMEM on day 16, and the heart ventricles of 16.5dpc fetal and 8-week-old mice.Journal of Biomedicine and Biotechnology 9
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Figure 4: The pharmacological reactions of the P19CL6-A1-derived cardiomyocytes. The contraction rhythms of the beating cells are
analyzed on the moving images before and after addition of the serial dilutions of IBMX (a) and ouabain (c) using the VisoRhythm software
on which the temporal variations in the correlation coeﬃcient are calculated between the values of mean brightness of the reference frame
and those of other frames in the selected area (20 × 20pixels in white), and accordingly, the correlograms representing the contraction
rhythm of the beating cells are displayed by the vertical coeﬃcient and horizontal time axis. ((b) and (d)) The median eﬀective doses (ED50)
of IBMX (b) and ouabain (d) obtained from the dose-response curve based on the beating rates, on which the basal and maximum rates are
represented by 0 and 100%, are 950nM and 160nM, respectively.
investigations are necessary to elucidate whether multilayer
formation is a crucial trigger for diﬀerentiation and to
determine the molecular events occurring in the multilayer
regions in this instance.
We employed the double stimulation method using 5-
Aza and DMSO as suggested by Ohtsu et al. [12], as the
basal protocol for cardiomyocyte diﬀerentiation because it
elicited diﬀerentiation from the parent P19CL6 cells most
eﬃciently among the several diﬀerentiation methods as
long as it was in vitro in our laboratory. To apply it
to the clonal derivative, that is, to P19CL6-A1 cells, we
examined the optimum concentration and exposure time
of the inducers and accordingly, the protocol for eﬃcient
diﬀerentiation was modiﬁed as summarized in Table 1.T h e
optimum concentration of each inducer is the same as
that in the basal protocol, but the exposure time of 5-
Aza is 3-fold longer than that for the parent cells. An
almost equal and fair percentage of P19CL6 and P19CL6-
A1 cells were necrotic after treatment with 10μM 5-Aza
for 24 and 72 hours, respectively, in the monolayer culture,
and therefore, the P19CL6-A1 cells were more resistant to
more prolonged exposure to the DNA demethylating reagent
than the P19CL6 cells. Both cell types were much more
resistant to the reagent than the P19 cells because the P19
cells treated with 5–10μM 5-Aza in the monolayer culture
became totally necrotic [15]. In the present study, DMEM10 Journal of Biomedicine and Biotechnology
with 7.5% FBS of the composition of the diﬀerentiation
medium elicited diﬀerentiation from both P19CL6-A1 and
P19CL6 cells more eﬃciently than α-MEM with 6.5% FBS
and much more than α-MEM with 10% FBS (data not
shown),whichhasbeengenerallyusedforthediﬀerentiation
of P19 and P19CL6 cells [7, 11–15, 20–26]. After the 5-
Aza treatment, P19CL6-A1 cells proliferated slightly under
DMEM containing 1% DMSO and 7.5% FBS and could
form multicell layers in adhesion culture more extensively
than P19CL6 cells under α-MEM containing 1% DMSO
and 6.5% FBS. P19CL6-A1-derived beating cells appeared
mostly in the multilayer regions and formed clusters more
extensively in the multilayer regions than in monolayer
regions. These may indicate that more extensive multilayer
formation induces the cardiomyocytes to diﬀerentiate more
eﬃciently. However, using 10% FBS instead of 7.5% or 6.5%
could not elicit more eﬃcient diﬀerentiation of the cells
probably due to stable proliferation of the undiﬀerentiated
populations in the cells even in the diﬀerentiation media
containing 10% FBS. In the present study, we found that
1% DMSO is optimum for the diﬀerentiation of P19CL6
and P19CL6-A1 cells. It is generally used for diﬀerentiation
of P19 and P19CL6 cells [11–15, 20, 22–26]. Moreover,
a previous report has demonstrated that the eﬃciency of
colony formation of P19 cells in the presence of DMSO
indicates the absence of toxicity at concentrations of less
than 1% under α-MEM with 10% FBS [7]. Based on
these data, we suppose that the serum concentration in
combination with 1% DMSO is a considerable factor for
eﬃcient diﬀerentiation. In fact, the source and lot number
of FBS and calf serum used in diﬀerentiation are thought
to be crucial for successful cardiac diﬀerentiation from P19
cells [16] as well as from P19CL6 cells (RIKEN BioResource
Center, personal communication).
Inthepresentstudy,cardiac-speciﬁctranscriptionfactors
GATA4 and Nkx2-5 were expressed in untreated cells. In
most previous reports P19CL6 cells untreated with inducers
such as DMSO and 5-Aza expressed neither GATA4 nor
Nkx2-5 [12, 14, 20, 22, 24, 27]. However, there are a
few reports in which GATA4 and/or Nkx2-5 expressed in
P19CL6 cells before the treatment [23, 26]. In the present
study we used a medium containing 10% DMSO for cell
cryopreservation and cells cultured for 1 day after thawing
as untreated cells (day 0) for the experiments. We suppose
this caused the clear expressions because the untreated cells
contain cells already exposed to the DMSO as a cardiac
diﬀerentiation inducer probably at a high rate. There were
no diﬀerences in the diﬀerentiation eﬃciencies under an
inverted microscope between P19CL6-A1 cells with and
without subcultures after thawing (data not shown) and the
same ﬁnding was obtained on P19CL6 cells (Dr. Y Ohtsu,
Jichi Medical University, personal communication).
There are 2 isoforms of cardiac MHCs, namely α-a n d
ß-MHC. The former is characterized by a high ATPase
activity and a quick contraction velocity as compared to the
latter [28]. Alpha- and/or ß-MHC are often used as cardiac-
speciﬁc markers for determining the eﬃciencies of cardiac
diﬀerentiation of P19 and P19CL6 cells [8, 11, 13, 14, 20,
25]. In the present study, we showed that the expression
level of α-MHC mRNA in the P19CL6-A1 cells treated with
the inducers was signiﬁcantly and 1.77 times higher than
that in the P19CL6 cells and almost equal to that in the
heart ventricles of the mouse fetuses. This indicates a high
eﬃciency of cardiac diﬀerentiation of P19CL6-A1 cells. We
also compared the diﬀerentiation eﬃciency between the two
cells by using cardiac α-actin immunoﬂuorescence staining
and showed that the ratio of cardiac α-actin-positive cell
areas to total areas of microscopic ﬁelds in P19CL6-A1 cells
was 38.3% and 5.5 times higher than that in P19CL6 cells.
This indicates that the diﬀerentiation eﬃciency estimated by
the immunoﬂuorescence staining is 3.1 times higher than
that by the RT-PCR. This discrepancy is likely to be caused
by the multicell layer formation of P19CL6-A1 cells; the two-
dimensionally microscopic analysis may overestimate the
diﬀerentiation eﬃciency due to the elimination of a factor
in rate of formation of multicell layers and the estimation by
theRT-PCRmayrepresentthediﬀerentiationeﬃciencyclose
to a real value.
4.2. Cardiomyocytes from P19CL6-A1 Cells. P19- as well as
P19CL6-derived cardiomyocytes display an electrophysio-
logical phenotype of embryonic ventricular cardiomyocytes
based on the studies in which (1) they display a complete
set of functional ion channels, but only limited amount
of functional sodium channels, (2) the maximal diastolic
potential is rather low (approximately −40 to −60mV), and
(3) the shape and characteristics of the action potential of
these cells resemble those of primary isolated embryonic
cardiomyocytes [5, 21, 24, 29]. Thus, P19CL6-A1-derived
cardiomyocytes may have similar properties because they
are clonal derivatives of P19CL6 cells. They rhythmically
and spontaneously beat and form clusters much larger
than P19CL6-derived cardiomyocytes, and accordingly their
contractions are larger and more obvious as observed under
an inverted microscope. Therefore, P19CL6-A1-derived car-
diomyocytes may be suitable models for studies on the
cardiac structural and functional properties during normal
physiological and pathological states in vitro, particularly
studies on contraction rhythm analyses based on moving
images. For this purpose, that is, to ﬁgure out the temporal
variations in the beating rhythms in detail, we developed
the software, Visorhythm, to analyze them based on moving
images and chart correlograms displaying the oscillated
rhythms. To illustrate the availability of P19CL6-A1-derived
cardiomyocytes as physiologically functional cardiomyocytes
and the software as an analytical tool for detailed analysis
of beating rhythms, we employed IBMX and ouabain as
potent cardiotonic reagents [30, 31]. Additionally, we found
that the nonbeating cells started to contract rhythmically
after the addition of these reagents (data not shown). This
ﬁnding is supported by a previous study in which P19-
derived nonbeating cells generated action potentials upon
electrical stimulation [5] and indicates that the actual ratio
of P19CL6-A1-derived cardiomyocytes is higher than that of
the beating to nonbeating cells under the microscope.
There are largely two diﬀerent methods to analyze
beating rhythms of cardiomyocytes in vitro: one is anJournal of Biomedicine and Biotechnology 11
electrophysiological method to measure electrical potential
of cardiomyocytes and the other is a microscopic method
to measure oscillated motions of cardiomyocytes. As for
the former method, a culture plate equipped with micro-
electrode arrays having 64-channels are used to record
electrical potentials on cultured cardiomyocytes [32, 33].
It can analyze electrical activities of cardiomyocytes such
as conduction velocities and synchronization times. As for
microscopic methods, Micheletto et al. introduced a free-
running scanning near-ﬁeld optical microscopy setup to
observe live cardiomyocytes [34]. Weisensee et al. also
introduced an image analysis system using the video capture
board for real-time subtraction between frames of moving
images to analyze motions of beating cardiomyocytes [35].
Both tools can analyze beating rates and the relative strength
for inotropic force while they monitor only one object at
a time. Here we have introduced Visorhythm to analyze
temporal variations in beating rhythms of cardiomyocytes
based on moving images and chart correlograms displaying
the oscillated rhythms. This software can analyze beating
rates easily. Yamauchi et al. had developed a similar software
on which the temporal variations in beating rhythms could
be analyzed in 1 ﬁxed area (20 ×20pixels) chosen arbitrarily
[18]. In contrast, Visorhythm can analyze up to 6 such areas
(150–400pixels/area) on each frame of one moving image
simultaneously. Therefore it can also analyze synchroniza-
tion between cardiomyocytes.
In conclusion, we used double stimulation with 5-Aza
and DMSO in this study and showed that P19CL6-A1 cells,
a new clonal derivative of P19CL6 cells, diﬀerentiated into
cardiomyocytes more eﬃciently than the parent cells. We
introduced a new software, Visorhythm, that can analyze the
temporal variations in the beating rhythms and can chart
correlograms displaying the oscillated rhythms up to 6 areas
onasinglemovingimagesimultaneously.UsingP19CL6-A1-
derived cardiomyocytes and the software, we demonstrated
that the correlograms could clearly display the enhancement
of beating rates by cardiotonic reagents. These indicate that a
combination of P19CL6-A1 cells and Visorhythm is a useful
tool that can provide invaluable assistance in inotropic drug
discovery, drug screening, and toxicity testing.
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